(19)
(11) EP 0 502 105 A1

(12)

(43) Date of publication:
09.09.1992 Bulletin 1992/37

(21) Application number: 91900526.0

(22) Date of filing: 20.11.1990
(51) International Patent Classification (IPC): 
A61K 39/ 21( . )
C07K 14/ 15( . )
C07K 14/ 16( . )
C07K 14/ 705( . )
C12N 15/ 09( . )
A61K 39/ 00( . )
C07K 14/ 005( . )
C07K 14/ 155( . )
C07K 14/ 195( . )
C12N 5/ 10( . )
C12P 21/ 02( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1990/006798
(87) International publication number:
WO 1991/007425 (30.05.1991 Gazette 1991/12)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 20.11.1989 US 19890439205

(71) Applicant: ONCOGEN LIMITED PARTNERSHIP
Seattle, WA 98121 (US)

(72) Inventors:
  • HAFFAR, Omar, K.
    Seattle, WA 98109 (US)
  • HU, Shiu-Lok
    Redmond, WA 98052 (US)
  • SENEAR, Allen, W.
    Seattle, WA 98103 (US)
  • TRAVIS, Bruce, M.
    Seattle, WA 98115 (US)

(74) Representative: Hirsch, Marc-Roger, et al 
Cabinet Hirsch 34 rue de Bassano
F-75008 Paris
F-75008 Paris (FR)

   


(54) NON-REPLICATING RECOMBINANT-MADE RETROVIRAL PARTICLES USED AS ANTIVIRAL AGENTS AND IMMUNOGENS